Linda Wagner-Weiner to Antirheumatic Agents
This is a "connection" page, showing publications Linda Wagner-Weiner has written about Antirheumatic Agents.
Connection Strength
0.909
-
Pediatric rheumatology for the adult rheumatologist. J Clin Rheumatol. 2008 Apr; 14(2):109-19.
Score: 0.265
-
Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis. J Rheumatol. 2021 07; 48(7):1073-1081.
Score: 0.161
-
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Arthritis Rheumatol. 2019 03; 71(3):451-459.
Score: 0.140
-
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease. Arthritis Rheumatol. 2018 09; 70(9):1508-1518.
Score: 0.136
-
Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome. Pediatr Ann. 2015 Jun; 44(6):e142-7.
Score: 0.109
-
Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study. Ann Rheum Dis. 2024 Oct 21; 83(11):1561-1571.
Score: 0.052
-
Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J Rheumatol. 2003 Feb; 30(2):394-400.
Score: 0.046